Wildy Logo
(020) 7242 5778
enquiries@wildy.com

Book of the Month

Cover of Borderlines in Private Law

Borderlines in Private Law

Edited by: William Day, Julius Grower
Price: £90.00

Lord Denning: Life, Law and Legacy



  


Welcome to Wildys

Watch


NEW EDITION
The Law of Rights of Light 2nd ed



 Jonathan Karas


Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Access to Medicines and Vaccines: Implementing Flexibilities Under Intellectual Property Law

Edited by: Carlos M. Correa, Reto M. Hilty

ISBN13: 9783030831165
Published: October 2021
Publisher: Springer-Verlag
Country of Publication: Switzerland
Format: Paperback
Price: £34.99



Despatched in 7 to 9 days.

This book is the outcome of a Global Forum on Innovation, Intellectual Property and Access to Medicines held in December 2019 at the Max Plank Instititute in Munich, organised by the South Centre and the Max Plank Institute. The academics and experts from international organisations participating have contributed chapters to this book. The book is for policy makers (in Ministries of Health, Ministries of Trade, Ministries of Foreign Affairs, patent offices), but also relevant for academics (law, trade, public health), on the flexibilities available in the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization to promote access to medicines.

Subjects:
Intellectual Property Law, Medical Law and Bioethics
Contents:
Interpreting the flexibilities under the TRIPS agreement
Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review
Compulsory license and government use
Access to genome editing technologies
Bolar exception
Patent oppositions in India
Protection of clinical test data
Courts and Pharmaceutical Patents
Robust Patent Examination or Deep Harmonization? Cooperation and Work Sharing between Patent Offices
IPRs, Competition Law and excessive pricing of medicines
The impact of TRIPS plus rules
Patent Linkages and its Impact on Access to Medicines;